ExploreWatchlistsPricing
  1. JP-listed companies
  2. OLYMPUS CORPORATION
  3. Financials
  4. Revenue

OLYMPUS CORPORATION (7733)

Market cap
¥1.79T
P/E ratio
18.6x
Olympus manufactures medical endoscopes and therapeutic devices for hospitals and healthcare providers worldwide, specializing in gastrointestinal, surgical, and diagnostic equipment.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 2025997,332+6.53%
Mar 31, 2024936,210+6.16%
Mar 31, 2023881,923+1.50%
Mar 31, 2022868,867+18.93%
Mar 31, 2021730,544-8.39%
Mar 31, 2020797,411+0.45%
Mar 31, 2019793,862+0.62%
Mar 31, 2018788,996+5.47%
Mar 31, 2017748,050-7.03%
Mar 31, 2016804,578+5.22%
Mar 31, 2015764,671+7.20%
Mar 31, 2014713,286-4.11%
Mar 31, 2013743,851-12.34%
Mar 31, 2012848,548

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat